RxDoctor Payments Data

Edward Akeyson, MD

Neurological Surgery · Alcoa, TNNPI 1427079789

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $25,593 of the $38,335 with a category attached, or 66.8%. 21 manufacturers reported payments, led by Surgalign Spine Technologies, Inc. at 45.2% of the total. Reporting peaked in 2020 at $17,314 and has fallen 84.3% since, to $2,724 in 2025.

$38,335in general payments, 2019–2025

Across 135 payments — averaging $283.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Surgalign Spine Technologies, Inc.$17K
  • The Institute Of Musculoskeletal Science And Education$8K
  • Nanohive Medical LLC$4K
  • Smoky Mountain Surgical LLC$2K
  • Alphatec Spine, Inc$2K
  • Camber Spine Technologies LLC$2K
  • plus $4K from 15 others

What the payments were for

  • Royalty or licence$1,7475%
  • Consulting fees$25,59367%
  • Travel & lodging$6,36717%
  • Food & beverage$4,62812%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$38,335 in reported general payments places this provider in the 80th percentile of 156 neurological surgery providers in Tennessee.

See all neurological surgery providers in Tennessee

Medicare billing

Part B allowed, 2024
$120,288
Medicare patients
154
Services billed
444

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methocarbamol42$422
Tramadol Hcl13$52

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Alcoa

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →